And do you think the FDA is going to green light an IND just because they gave it a number?
The PR itself leads more to longer timeframe than shorter timeframe since it says it is going to be a process like HemaXellerate which an IND# was given to in early 2013. So then, why would anyone conclude that FDA approval for clinical trials of dCellVax are near?